Jason Politi
Technik-/Wissenschafts-/F&E-Leiter bei VERVE THERAPEUTICS, INC.
Profil
Jason Politi is currently the Chief Technical Operations Officer at Verve Therapeutics, Inc. Prior to his current position, he held the role of Senior Director-Clinical Manufacturing at Alexion Pharmaceuticals, Inc. and Senior Vice President-Technical Operations at Prevail Therapeutics, Inc. Mr. Politi completed his undergraduate degree at Massachusetts Institute of Technology and holds an MBA from Boston College.
Aktive Positionen von Jason Politi
| Unternehmen | Position | Beginn |
|---|---|---|
| VERVE THERAPEUTICS, INC. | Technik-/Wissenschafts-/F&E-Leiter | 01.02.2021 |
Ehemalige bekannte Positionen von Jason Politi
| Unternehmen | Position | Ende |
|---|---|---|
| ALEXION PHARMACEUTICALS, INC. | Corporate Officer/Principal | - |
| PREVAIL THERAPEUTICS INC. | Technik-/Wissenschafts-/F&E-Leiter | - |
Ausbildung von Jason Politi
| Massachusetts Institute of Technology | Undergraduate Degree |
| Boston College | Masters Business Admin |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| VERVE THERAPEUTICS, INC. | Health Technology |
| Private Unternehmen | 2 |
|---|---|
Prevail Therapeutics, Inc.
 Prevail Therapeutics, Inc. BiotechnologyHealth Technology Prevail Therapeutics, Inc. develops therapeutics for neurodegenerative diseases. The firm engages in the research and development of novel biologic gene therapies to treat Parkinson's disease and other neurodegenerative diseases. The company was founded by Asa Abeliovich on July 6, 2017 and is headquartered in New York, NY. | Health Technology |
Alexion Pharmaceuticals, Inc.
 Alexion Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Alexion Pharmaceuticals, Inc. engages in the business of serving patients and families affected by rare diseases and devastating conditions through the discovery, development, and commercialization of life-changing medicines. The firm also focuses on the development of haematology, nephrology, neurology, metabolic disorders, cardiology, and ophthalmology. The company was founded by Joseph A. Madri, David W. Keiser, Stephen P. Squinto, and Leonard Bell in January 1992 and is headquartered in Boston, MA. | Health Technology |
